168 related articles for article (PubMed ID: 33583321)
1. Statins can benefit patients with primary membranous nephropathy on venous thromboembolism.
Zou P; Li H; Cai J; Chen Z; Li C; Li X
Ren Fail; 2021 Dec; 43(1):302-306. PubMed ID: 33583321
[TBL] [Abstract][Full Text] [Related]
2. Dose-related effect of statins in venous thrombosis risk reduction.
Khemasuwan D; Chae YK; Gupta S; Carpio A; Yun JH; Neagu S; Lucca AB; Valsecchi ME; Mora JI
Am J Med; 2011 Sep; 124(9):852-9. PubMed ID: 21783169
[TBL] [Abstract][Full Text] [Related]
3. Association of statins, aspirin, and venous thromboembolism in women with endometrial cancer.
Matsuo K; Hom MS; Yabuno A; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
Gynecol Oncol; 2019 Mar; 152(3):605-611. PubMed ID: 30616901
[TBL] [Abstract][Full Text] [Related]
4. Serum PLA2R antibody as a predictive biomarker for venous thromboembolism risk in primary membranous nephropathy.
Li J; Wang X; Jiang S; Li W
Med Clin (Barc); 2023 Nov; 161(10):417-421. PubMed ID: 37532619
[TBL] [Abstract][Full Text] [Related]
5. The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy.
Zou P; Li H; Cai J; Li C; Chen Z; Li X
Ren Fail; 2019 Nov; 41(1):623-628. PubMed ID: 31269849
[No Abstract] [Full Text] [Related]
6. Statins, aspirin and risk of thromboembolic events in ovarian cancer patients.
Shai A; Rennert HS; Rennert G; Sagi S; Leviov M; Lavie O
Gynecol Oncol; 2014 May; 133(2):304-8. PubMed ID: 24631448
[TBL] [Abstract][Full Text] [Related]
7. A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy.
Zou PM; Li H; Cai JF; Chen ZJ; Li C; Xu P; Li MX; Chen LM; Li XM; Li XW
Chin Med Sci J; 2018 Jun; 33(2):91-99. PubMed ID: 29976278
[TBL] [Abstract][Full Text] [Related]
8. Venous Thromboembolism in Primary Nephrotic Syndrome - Is the Risk High Enough to Justify Prophylactic Anticoagulation?
Rankin AJ; McQuarrie EP; Fox JG; Geddes CC; MacKinnon B;
Nephron; 2017; 135(1):39-45. PubMed ID: 27669572
[TBL] [Abstract][Full Text] [Related]
9. Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study.
Tagalakis V; Eberg M; Kahn S; Azoulay L
Thromb Haemost; 2016 Jun; 115(6):1220-8. PubMed ID: 26819144
[TBL] [Abstract][Full Text] [Related]
10. Preinjury statin use and thromboembolic events in trauma: a 10-year retrospective evaluation.
McMahon RA; Fletcher JL; Aden JK; Holland SR; Trexler ST; Blackbourne LH
J Surg Res; 2018 Jun; 226():100-111. PubMed ID: 29661275
[TBL] [Abstract][Full Text] [Related]
11. Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism.
Resh M; Mahmoodi BK; Navis GJ; Veeger NJ; Lijfering WM
Thromb Res; 2011 May; 127(5):395-9. PubMed ID: 21277007
[TBL] [Abstract][Full Text] [Related]
12. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials.
Zaccardi F; Kunutsor SK; Seidu S; Davies MJ; Khunti K
Atherosclerosis; 2018 Apr; 271():223-231. PubMed ID: 29524865
[TBL] [Abstract][Full Text] [Related]
13. Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study.
Schmidt M; Cannegieter SC; Johannesdottir SA; Dekkers OM; Horváth-Puhó E; Sørensen HT
J Thromb Haemost; 2014 Aug; 12(8):1207-15. PubMed ID: 24818818
[TBL] [Abstract][Full Text] [Related]
14. Effect of Statins on Recurrent Venous Thromboembolism (from the COMMAND VTE Registry).
Yoshikawa Y; Yamashita Y; Morimoto T; Mabuchi H; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Murakami T; Kimura T;
Am J Cardiol; 2020 Jan; 125(2):189-197. PubMed ID: 31744599
[TBL] [Abstract][Full Text] [Related]
15. Statins decrease the occurrence of venous thromboembolism in patients with cancer.
Khemasuwan D; Divietro ML; Tangdhanakanond K; Pomerantz SC; Eiger G
Am J Med; 2010 Jan; 123(1):60-5. PubMed ID: 20102993
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
Skajaa N; Nagy D; Troelsen FS; Farkas DK; Sørensen HT
Thromb Res; 2021 May; 201():1-5. PubMed ID: 33621859
[TBL] [Abstract][Full Text] [Related]
17. Statin Therapy and the Incidence of Thromboembolism and Vascular Events Following Liver Transplantation.
Frasco PE; Aqel B; Alvord JM; Poterack KA; Bauer I; Mathur AK
Liver Transpl; 2021 Oct; 27(10):1432-1442. PubMed ID: 33964102
[TBL] [Abstract][Full Text] [Related]
18. The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis.
Al Harbi SA; Khedr M; Al-Dorzi HM; Tlayjeh HM; Rishu AH; Arabi YM
BMC Pharmacol Toxicol; 2013 Nov; 14():57. PubMed ID: 24206781
[TBL] [Abstract][Full Text] [Related]
19. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
20. Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis.
Barbour SJ; Greenwald A; Djurdjev O; Levin A; Hladunewich MA; Nachman PH; Hogan SL; Cattran DC; Reich HN
Kidney Int; 2012 Jan; 81(2):190-5. PubMed ID: 21918501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
